Last updated on June 2012

SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less


Brief description of study

SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01272037?term=SWOG+S1007&rank=1

Clinical Study Identifier: TX135976

Contact Investigators or Research Sites near you

Start Over

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »